Researchers continue to excited about the medication , a novel dual treatment showing remarkable outcomes in initial trials for size loss . It acts by impacting two pathways : GLP-1 and GIP, that , when https://laylahenu364180.ezblogz.com/72577490/this-new-possibility-for-size-loss